
Bayer promises ‘first‑to‑the‑farm’ innovation as shareholders push back
Bayer’s 2026 Annual Stockholders’ Meeting laid bare investor patience wearing thin over the Monsanto acquisition and US glyphosate litigation, even as CEO Bill Anderson pointed to early signs of operational progress. For agriculture, the message was...














































